Objective: To compare the immediate effect of xylitol chewing gum and xylitol mouth rinse on mutans streptococci (MS) levels in the saliva of adults with systemic sclerosis (SSc).
Introduction
Systemic sclerosis (SSc) belongs to a group of autoimmune connective tissue disorders, which are characterized by inflammation and excessive fibrosis of connective tissue [1] . SSc affects the oral and peri-oral tissues as well as skin and musculoskeletal tissue on the hands. Orofacial complications (microstomia and xerostomia), and manual dexterity impairments (loss of finger pad tissue, digital ulcers, and hand deformity) are two major clinical manifestations that may interfere with normal oral hygiene and contribute to increase risk of oral health problems in people with SSc [2, 3] . Compared to sex-matched healthy controls, a higher proportion of people with SSc exhibited more dental caries experience, and periodontal disease [4, 5] . With a high risk of dental disease in this population, plaque removal from tooth surfaces through regular oral self-care is essential.
Xylitol, a naturally occurring sugar alcohol sweetener, has been shown to decrease mutans streptococci (MS) levels, plaque formation, and the incidence of caries [6] [7] [8] [9] [10] . Although xylitol chewing gum has shown promise as an anticariogenic agent it may not be practical for people with SSc. A large proportion of people with SSc suffer from conditions such as osteolysis, temporomandibular disorders, and trigeminal neuropathy, which can lead to facial pain during prolonged repetitive movements such as chewing gum [4, 5, 11, 12] . In this patient population, an aqueous form of xylitol, such as a mouth rinse, may be a useful alternative delivery system. In addition to reduced preparation costs, an oral xylitol solution that is expectorated may circumvent gastrointestinal complaints such as diarrhea in people who are less tolerant to high doses of xylitol [13] . The objective of this study is to compare the immediate effect of xylitol chewing gum and xylitol mouth rinse on MS levels in the saliva of adults with SSc.
Materials and methods

Participants
A convenience sample of 13 adults with SSc was drawn from a pool of patients who had participated in the first author's oral health epidemiological study at the Medical University of South Carolina (MUSC). To be eligible for the study, adults had a diagnosis of SSc and their diagnoses fulfilled the American College of Rheumatology preliminary classification criteria for SSc [14] , at least 20 natural teeth, and were older than 18 years of age. The exclusion criteria were localized scleroderma (e.g. morphea, linear scleroderma, and en coup de sabre), or complaint of jaw joint pain during chewing.
Procedures One to two days before the study appointment, potential participants were contacted by phone and instructed to refrain from performing any oral selfcare procedures or using chewing gum the morning before the appointment and to refrain from smoking, eating, or drinking (except water) two hours immediately prior to the appointment. The study was conducted in a research laboratory at MUSC. A written, informed consent was obtained from all participants before initiation of the study protocol. The protocol was approved by the Institutional Review Board at the MUSC. The study employed a randomized comparative trial design.
Treatment protocol and sample collection At the research laboratory, participants were instructed to rinse their mouth with distilled water for 20 seconds, and then to swallow any excess saliva. As per the supplied manufacturer's protocol, a trained dental student (J.D.) pressed the rough surface of a Dentocult ® SM Strip mutans (Orion Diagnostica, Espoo, Finland) on the participant's tongue to collect MS, and removed the strip gently through the participant's closed lips. This served as the baseline data of the MS sample collection.
After baseline MS data collection, participants were assigned randomly to either the xylitol chewing gum or xylitol mouth rinse groups. Participants were given either 2 pellets of commercial xylitol chewing gum (Epic, each pellet contained 1.06 g of xylitol) to chew for 10 min (chewing gum group) or 10 ml of xylitol solution (10 ml of water containing 1 g of dissolved xylitol, 10% [w/v], prepared by a pharmacist) to rinse mouth for 2 min (mouth rinse group). Lif Holgerson et al [15] has shown that administration of 1.32 g of xylitol chewing gum for 5 min or 1.0 g of dissolved xylitol mouth rinse for 2 min produced a similar level of xylitol in the saliva at 8-16 min after intake. In addition, previous studies have demonstrated that MS growth is significantly inhibited at a xylitol concentration of 1.56%, while xylitol concentrations of 12.5% or higher were required to inhibit the growth of other oral streptococci such as Streptococcus salivarius and Streptococcus sanguis [16] . Therefore, the dosing schedule employed in this study was expected to inhibit the growth of MS when delivered and released within the oral cavity.
For participants in the chewing gum group, they were instructed to remove the gum from their mouth at the end of the 10 min whereas for participants in the mouth rinse group, they were instructed to expectorate the rinse at the end of the 2 min. The dental student then collected the second MS sample using Dentocult ® SM Strip mutans as described above. The participant then waited for 25 min without consuming any food or liquid. During the waiting period, the participant completed a short oral health questionnaire and the dental student provided oral health information related to SSc to the participant. At the end of the 25 min, the dental student collected the third MS sample using the Dentocult ® SM Strip mutans. Relevant oral health information of the participants was also obtained from the oral health epidemiological study.
For consistency, the same trained dental student, familiar with the procedure and the test kit, performed the testing and scoring of all MS samples. MS testing and scoring procedures were performed according to the manufacturer's instructions [17] . The density of MS growth was measured by colony forming unit (CFU) ml -1 and the results were categorized using the Dentocult The dental student recorded the level of MS and then took images of all strips using a digital camera (Sony Cyber-shot DSC-W170 with 10.1 megapixels resolution). A microbiologist (C.W.), blinded to the participant's group assignment as well as the sequence of the strips, evaluated the strip images. An inter-rater agreement between the dental student and the microbiologist on evaluating the MS levels using Cohen's Kappa statistics was 0.87, which is considered to be excellent [18] . 
Results
All 13 participants were female of whom two were Black, and 11 were White. Two participants were diagnosed with diffuse cutaneous scleroderma, and 11 with limited cutaneous scleroderma. Their mean (±S.D.) age was 54.46±16.29 years old, ranging from 32 to 77 years old. The mean (±S.D.) years of diagnosis with SSc was 13.46±12.57 ranging from 1 to 41. All but one participant reported having symptoms of mouth dryness and gastroesophageal reflux. Characteristics of the 13 participants in each group are shown in Table 1 .
We tested the hypotheses of whether there was significant difference in MS levels between the two groups (chewing gum and mouth rinse) on (a) change in score from baseline to post 10 min chewing xylitol gum / 2 min xylitol mouth rinsing, and (b) change in score from baseline to 25 min post xylitol exposure. We used nonparametric Mann-Whitney U test with exact p-values to test the hypotheses between groups. No significant difference in MS score between the two groups was observed in each time interval at the 5% level of significance. No adverse effects were reported at the end of the 25 min from either group.
Discussion
Based on the findings, it appears the effect of xylitol chewing gum on total MS levels in saliva does not differ from that of xylitol mouth rinse. These findings are consistent with the literature on no significant difference between xylitol chewing gum and xylitol mouth rinse for 3 months of daily exposure on MS levels [19] . The lack of significance observed in each time interval between the groups for the MS scores and no adverse effects were reported after xylitol exposure may indicate that the mouth rinse can be an alternative safe mode of xylitol exposure in the mouth cavity for adults with SSc [20] . Further study may increase the dosage as well as frequency and duration of xylitol mouth rinse exposure to determine the optimal regimen to inhibit the growth of MS in the oral cavity.
